Vandenbroucke JP - Search Results

1

Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants.

van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briët E. van der Meer FJ, et al. Among authors: vandenbroucke jp. Thromb Haemost. 1996 Jul;76(1):12-6. Thromb Haemost. 1996. PMID: 8819244

2

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briët E. Cannegieter SC, et al. Among authors: vandenbroucke jp. N Engl J Med. 1995 Jul 6;333(1):11-7. doi: 10.1056/NEJM199507063330103. N Engl J Med. 1995. PMID: 7776988 Free article.

3

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Vandenbroucke JP, et al. Lancet. 1994 Nov 26;344(8935):1453-7. doi: 10.1016/s0140-6736(94)90286-0. Lancet. 1994. PMID: 7968118 Free article.

4

Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).

Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briët E, Vandenbroucke JP. Koster T, et al. Among authors: vandenbroucke jp. Thromb Haemost. 1994 Jun;71(6):719-22. Thromb Haemost. 1994. PMID: 7974338

5

Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briët E. van der Meer FJ, et al. Among authors: vandenbroucke jp. Arch Intern Med. 1993 Jul 12;153(13):1557-62. doi: 10.1001/archinte.153.13.1557. Arch Intern Med. 1993. PMID: 8323419 Free article.

6

Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.

Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Bertina RM, et al. Among authors: vandenbroucke jp. Thromb Haemost. 1995 Jul;74(1):449-53. Thromb Haemost. 1995. PMID: 8578504 Review.

7

Mortality and causes of death in inherited antithrombin deficiency.

van Boven HH, Vandenbroucke JP, Westendorp RG, Rosendaal FR. van Boven HH, et al. Among authors: vandenbroucke jp. Thromb Haemost. 1997 Mar;77(3):452-5. Thromb Haemost. 1997. PMID: 9065992 Free article.

8

End of the line for "third-generation-pill" controversy?

Vandenbroucke JP, Rosendaal FR. Vandenbroucke JP, et al. Lancet. 1997 Apr 19;349(9059):1113-4. doi: 10.1016/S0140-6736(05)63015-2. Lancet. 1997. PMID: 9113005

9

Oral contraceptives and thrombotic disease: risk of venous thromboembolism.

Helmerhorst FM, Bloemenkamp KW, Rosendaal FR, Vandenbroucke JP. Helmerhorst FM, et al. Among authors: vandenbroucke jp. Thromb Haemost. 1997 Jul;78(1):327-33. Thromb Haemost. 1997. PMID: 9198174 Free article. Review.

10

The Leiden Thrombophilia Study (LETS).

van der Meer FJ, Koster T, Vandenbroucke JP, Briët E, Rosendaal FR. van der Meer FJ, et al. Among authors: vandenbroucke jp. Thromb Haemost. 1997 Jul;78(1):631-5. Thromb Haemost. 1997. PMID: 9198229 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

625 results

Search Page

Filters